Clinical Trial Results

Research Sponsor: AstraZeneca AB

Drug Studied: Roxadustat

Trial Purpose: This trial was done to learn how roxadustat works and about its safety in people with low levels of iron in their blood from chronic kidney disease.

Protocol Number: D5741C00002

Thank you

Thank you to the participants who took part in the clinical trial for the trial drug roxadustat. All of the participants helped researchers learn more about roxadustat to help people with low levels of iron in their blood from chronic kidney disease. AstraZeneca AB sponsored this trial and believes it is important to share the results of this trial with the participants and the public. AstraZeneca AB reviewed the results of this trial when it ended and created a report of those results. This is a summary of that report.

An independent non-profit organization called CISCRP helped prepare this summary of the trial results. We hope it helps the participants understand and feel proud of their important role in medical research.

If you participated in this trial and have questions about the results, please speak with a trial doctor or staff at your trial site.